Emergent BioSolutions (EBS)
6.20
0.00 (0.00%)
Upcoming Events
Latest Headlines
Emergent BioSolutions stock falls as CFO plans retirement
October 16, 2026 11:47 AM - StreetInsider
Emergent BioSolutions CFO Richard Lindahl to retire end of 2026
October 16, 2026 7:50 AM - StreetInsider
Emergent BioSolutions Announces Retirement of Chief Financial Officer Richard S. Lindahl
October 16, 2026 7:50 AM - BizWire
Form 8-K Emergent BioSolutions For: Oct 16
October 16, 2026 7:48 AM - SEC Filing
Emergent BioSolutions to Report Third Quarter 2026 Financial Results on November 2, 2026
October 15, 2026 8:00 AM - BizWire
Form 144 Emergent BioSolutions Filed by: DeGolyer Donald W
October 7, 2026 4:04 PM - SEC Filing
Form 4 Emergent BioSolutions For: Oct 07 Filed by: DeGolyer Donald W
October 7, 2026 3:45 PM - SEC Filing
US Escalates Pressure On Russia Over Siberia Lab Death - WSJ
October 6, 2026 3:56 PM - StreetInsider
Trump On Plague: Looking At It Very Strongly - Bloomberg
October 5, 2026 3:29 PM - StreetInsider
Rubio urges calm as U.S. tracks suspected pneumonic plague death at Russian lab
October 5, 2026 10:33 AM - StreetInsider
Form 4 Emergent BioSolutions For: Oct 01 Filed by: Williams Paul Anthony
October 5, 2026 9:16 AM - SEC Filing
Form 144 Emergent BioSolutions Filed by: Williams Paul Anthony
October 1, 2026 4:20 PM - SEC Filing
Media Advisory: Emergent to Host Ribbon Cutting Ceremony at Canton Manufacturing Facility
September 15, 2026 7:45 AM - StreetInsider
Form 8-K Emergent BioSolutions For: Sep 14
September 14, 2026 4:02 PM - SEC Filing
Emergent BioSolutions buys back $75M in senior unsecured notes
September 3, 2026 7:45 AM - StreetInsider
Emergent BioSolutions Completes Repurchase of $75 Million Aggregate Principal Amount of Senior Unsecured Notes
September 3, 2026 7:45 AM - StreetInsider
Form 8-K Emergent BioSolutions For: Aug 18
September 1, 2026 4:13 PM - SEC Filing
Emergent BioSolutions gets $24M BARDA contract for anthrax vaccine
September 1, 2026 7:55 AM - StreetInsider
Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)
September 1, 2026 7:55 AM - StreetInsider
Emergent BioSolutions wins Canada NARCAN supply deal through 2029
August 31, 2026 7:55 AM - StreetInsider
Emergent BioSolutions Awarded Government of Canada Standing Offer for NARCAN® Nasal Spray
August 31, 2026 7:55 AM - StreetInsider
Emergent BioSolutions Reinforces Commitment to Opioid Overdose Education and Preparedness on International Overdose Awareness Day
August 31, 2026 7:54 AM - StreetInsider
JPMorgan Reinstates Emergent BioSolutions (EBS) at Underweight
August 21, 2026 3:28 AM - StreetInsider
Form SCHEDULE 13G Emergent BioSolutions Filed by: AMERICAN CENTURY INVESTMENT MANAGEMENT INC
August 14, 2026 2:37 PM - SEC Filing
Form 3 Emergent BioSolutions For: Aug 05 Filed by: Duatschek Stephanie
August 12, 2026 9:17 AM - SEC Filing
Emergent BioSolutions (EBS) PT Lowered to $10 at H.C. Wainwright
August 10, 2026 6:49 AM - StreetInsider
Form 10-Q Emergent BioSolutions For: Jun 30
August 6, 2026 6:02 AM - SEC Filing
Emergent BioSolutions (EBS) Tops Q2 EPS by 49c
August 6, 2026 2:17 AM - StreetInsider
Emergent BioSolutions highlights biological threat risks amid AI advances
August 5, 2026 4:08 PM - StreetInsider
Form 8-K Emergent BioSolutions For: Aug 05
August 5, 2026 4:07 PM - SEC Filing
Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment
August 5, 2026 4:07 PM - Globe NewsWire
Emergent BioSolutions Reports Second Quarter 2026 Financial Results
August 5, 2026 4:07 PM - StreetInsider
Form SCHEDULE 13G/A Emergent BioSolutions Filed by: VANGUARD CAPITAL MANAGEMENT LLC
July 31, 2026 10:21 AM - SEC Filing
Form SCHEDULE 13G/A Emergent BioSolutions Filed by: BlackRock, Inc.
July 28, 2026 4:45 PM - SEC Filing
Full Article List
